Brazil disburses US$10m for renal replacement boost
This article was originally published in Clinica
Executive Summary
Brazil is spending an additional R$16.5m (US$10.5m) on improving access to renal replacement services in 19 states. Some 70,000 patients under the care of the public health service,Sistema �nico de Saúde (SUS), will benefit, claims the federal government. The 19 states are: Alagoas, Bahia, Cear�, Goi�s, Maranhão, Mato Grosso, Minas Gerais (which will receive the largest share: R$4.36m), Mato Grosso do Sul, Par�, Paran�, Pernambuco (R$1.35bn), Piauí, Rio de Janeiro, Rio Grande do Norte, Rio Grande do Sul (R$1.3bn), Rondônia, Santa Catarina, São Paulo (R$2.1bn) and Sergipe. Under a similar initiative in 2010, haemodialysis was the leading beneficiary of a R$200m one-off investment, which resulted in a 7.5% increase in renal replacement procedures, according to the health ministry.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.